TrialJournal of lipid research2019

Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis.

Michael B Boffa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.